Novel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced Lipophilicity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Plechanovova, Anna | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.contributor.author | Alquicer, Glenda | - |
dc.contributor.author | Skultetyova, L'ubica | - |
dc.contributor.author | Mlcochova, Petra | - |
dc.contributor.author | Nemcova, Adriana | - |
dc.contributor.author | Kim, Hyung-Joon | - |
dc.contributor.author | Navratil, Michal | - |
dc.contributor.author | Mease, Ronnie | - |
dc.contributor.author | Lubkowski, Jacek | - |
dc.contributor.author | Pomper, Martin | - |
dc.contributor.author | Konvalinka, Jan | - |
dc.contributor.author | Rulisek, Lubomir | - |
dc.contributor.author | Barinka, Cyril | - |
dc.date.accessioned | 2021-09-07T06:18:27Z | - |
dc.date.available | 2021-09-07T06:18:27Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-11-10 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111154 | - |
dc.description.abstract | Virtually all low molecular weight inhibitors of human glutamate carboxypeptidase II (GCPII) are highly polar compounds that have limited use in settings where more lipophilic molecules are desired. Here we report the identification and characterization of GCPII inhibitors with enhanced liphophilicity that are derived from a series of newly identified dipeptidic GCPII substrates featuring nonpolar aliphatic side chains at the C-terminus. To analyze the interactions governing the substrate recognition by GCPII, we determined crystal structures of the inactive GCPII(E424A) mutant in complex with selected dipeptides and complemented the structural data with quantum mechanics/molecular mechanics calculations. Results reveal the importance of nonpolar interactions governing GCPII affinity toward novel substrates as well as formerly unnoticed plasticity of the S1' specificity pocket. On the basis of those data, we designed, synthesized, and evaluated a series of novel GCPII inhibitors with enhanced lipophilicity, with the best candidates having low nanomolar inhibition constants and clogD > -0.3. Our findings offer new insights into the design of more lipophilic inhibitors targeting GCPII. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | UREA-BASED INHIBITORS | - |
dc.subject | MEMBRANE ANTIGEN | - |
dc.subject | DIABETIC-NEUROPATHY | - |
dc.subject | MORPHINE-TOLERANCE | - |
dc.subject | ACTIVE-SITE | - |
dc.subject | BASIS-SETS | - |
dc.subject | GCP-II | - |
dc.subject | NAALADASE | - |
dc.subject | EXPRESSION | - |
dc.subject | DESIGN | - |
dc.title | Novel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced Lipophilicity | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Byun, Youngjoo | - |
dc.identifier.doi | 10.1021/jm200807m | - |
dc.identifier.scopusid | 2-s2.0-80455140560 | - |
dc.identifier.wosid | 000296408100010 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.54, no.21, pp.7535 - 7546 | - |
dc.relation.isPartOf | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 54 | - |
dc.citation.number | 21 | - |
dc.citation.startPage | 7535 | - |
dc.citation.endPage | 7546 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | UREA-BASED INHIBITORS | - |
dc.subject.keywordPlus | MEMBRANE ANTIGEN | - |
dc.subject.keywordPlus | DIABETIC-NEUROPATHY | - |
dc.subject.keywordPlus | MORPHINE-TOLERANCE | - |
dc.subject.keywordPlus | ACTIVE-SITE | - |
dc.subject.keywordPlus | BASIS-SETS | - |
dc.subject.keywordPlus | GCP-II | - |
dc.subject.keywordPlus | NAALADASE | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | DESIGN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.